Center-Authored Papers

Filters: Author is Storb, Rainer F  [Clear All Filters]
Journal Article
Matesan M, Rajendran J, Press OW, Maloney DG, Storb RF, Cassaday RD, Pagel JM, Oliveira G, Gopal AK.  2014.  90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.. Nuclear medicine communications. 35(11):1132-42. Abstract
Gopal AK, Guthrie KA, Rajendran J, Pagel JM, Oliveira G, Maloney DG, Matesan MC, Storb R, Press OW.  2011.  90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.. Blood. 118(4):1132-9. Abstract
Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK.  2005.  Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(15):3439-46. Abstract
Mielcarek M, Torok-Storb B, Storb R.  2002.  ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.. Bone marrow transplantation. 30(8):547-8;authorreply548.
Swearingen B, Chang J, Butts T, Graves S, Storb R, Mathes DW.  2014.  Achieving Tolerance in a Mismatched VCA Transplant While Reducing The Risk of GVHD: Goal of Transient Chimerism.. Transplantation. 98:409-410. Abstract
Parker MH, Loretz C, Tyler AE, Duddy WJ, Hall JK, Olwin BB, Bernstein ID, Storb R, Tapscott SJ.  2012.  Activation of Notch Signaling During ex vivo Expansion Maintains Donor Muscle Cell Engraftment.. Stem cells (Dayton, Ohio). Abstract
Graves SS, Hogan WJ, Kuhr C, Diaconescu R, Harkey M, Sale GE, Stone B, Georges GE, Storb R.  2008.  Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1201-8. Abstract
Bensinger WI, Rotta M, Storer B, Chauncey T, Holmberg L, Becker P, Sandmaier BM, Storb R, Maloney D.  2012.  Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.. Bone marrow transplantation. 47(10):1312-7. Abstract
Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R et al..  2004.  Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.. Bone marrow transplantation. 33(8):805-14. Abstract
Shustov AR, Gooley TA, Sandmaier BM, Shizuru J, Sorror ML, Sahebi F, McSweeney P, Niederwieser D, Bruno B, Storb R et al..  2010.  Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.. British journal of haematology. 150(2):170-8. Abstract
Samuelson S, Sandmaier BM, Heslop HE, Popat U, Carrum G, Champlin RE, Storb R, Prchal JT, Gooley TA, Deeg HJ.  2011.  Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.. British journal of haematology. 153(1):76-82. Abstract
Shadman M, Hingorani S, Lanum SA, Pagel JM, Storb R, Maloney DG, Sandmaier BM.  2016.  Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience.. Leukemia & lymphoma. :1-3.
Pagel JM, Gooley TA, Rajendran J, Fisher DR, Wilson WA, Sandmaier BM, Matthews DC, Deeg HJ, Gopal AK, Martin PJ et al..  2009.  Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.. Blood. 114(27):5444-53. Abstract
Storb R, Gyurkocza B, Storer BE, Maloney DG, Sorror ML, Mielcarek M, Martin PJ, Sandmaier BM.  2013.  Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):792-8. Abstract
Eissa H, Gooley TA, Sorror ML, Nguyen F, Scott BL, Doney K, Loeb KR, Martin PJ, Pagel JM, Radich JP et al..  2011.  Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(6):908-15. Abstract
Burroughs LM, Shimamura A, Talano J-A, Domm J, Baker K, Delaney C, Frangoul H, Margolis D, Baker KS, Geddis A et al..  2017.  Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Doney K, Gooley TA, Deeg HJ, Flowers MED, Storb R, Appelbaum FR.  2011.  Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1187-95. Abstract
Gyurkocza B, Rezvani A, Storb R.  2010.  Allogeneic hematopoietic cell transplantation: the state of the art.. Expert review of hematology. 3(3):285-99. Abstract
Frost SHL, Miller BW, Bäck TA, Santos EB, Hamlin DK, Knoblaugh SE, Frayo SL, Kenoyer AL, Storb R, Press OW et al..  2015.  Alpha Imaging Confirmed Efficient Targeting of CD45-Positive Cells after Astatine-211 (211At)-Radioimmunotherapy for Hematopoietic Cell Transplantation.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(11):1766-73. Abstract
Wang Z, Storb R, Tapscott SJ, Riddell SR.  2012.  Analyzing Cellular Immunity to AAV in a Canine Model Using ELISPOT Assay.. Methods in molecular biology (Clifton, N.J.). 792:65-74. Abstract
Graves SS, Stone DM, Loretz C, Peterson LJ, Lesnikova M, Hwang B, Georges GE, Nash R, Storb R.  2011.  Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.. Transplantation. 91(8):833-40. Abstract
Rosinski SL, Storb R, Strong RK, Sale GE, Stone DM, Gewe MM, Friend DJ, Abrams KV, Randolph-Habecker J, Graves SS.  2015.  Anti-CD28 Antibody-Initiated Cytokine Storm in Canines.. Transplantation direct. 1(2) Abstract
Graves SS, Parker MH, Stone D, Sale GE, Pillai SPS, Johnson MM, Storb R.  2018.  Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(1):50-54. Abstract
Sorror ML, Storer B, Storb R.  2011.  Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights.. Bone marrow transplantation. 46(3):464-6.
Ram R, Storer BE, Mielcarek M, Sandmaier BM, Maloney DG, Martin PJ, Flowers MED, Chua BK, Rotta M, Storb R.  2012.  Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(3):414-422. Abstract